Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group.
Feliu J, López Alvarez MP, Jaraiz MA, Constenla M, Vicent JM, Belón J, López Gómez L, de Castro J, Dorta J, González Barón M. Feliu J, et al. Among authors: lopez gomez l, lopez alvarez mp. Cancer. 2000 Oct 15;89(8):1706-13. doi: 10.1002/1097-0142(20001015)89:8<1706::aid-cncr9>3.0.co;2-i. Cancer. 2000. PMID: 11042564 Clinical Trial.
Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.
Feliu J, Escudero P, Llosa F, Bolaños M, Vicent JM, Yubero A, Sanz-Lacalle JJ, Lopez R, Lopez-Gómez L, Casado E, Gómez-Reina MJ, González-Baron M. Feliu J, et al. Among authors: lopez r, gomez reina mj, lopez gomez l. J Clin Oncol. 2005 May 1;23(13):3104-11. doi: 10.1200/JCO.2005.06.035. J Clin Oncol. 2005. PMID: 15860870 Clinical Trial.
Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group.
Feliu J, López Gómez L, Madroñal C, Espinosa E, Espinosa J, Girón CG, Martínez B, Castro J, De la Gándara I, Barón MG. Feliu J, et al. Among authors: lopez gomez l. Cancer. 1999 Oct 15;86(8):1463-9. doi: 10.1002/(sici)1097-0142(19991015)86:8<1463::aid-cncr12>3.0.co;2-n. Cancer. 1999. PMID: 10526274 Clinical Trial.
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.
Feliu J, Mel R, Borrega P, López Gómez L, Escudero P, Dorta J, Castro J, Vázquez-Estévez SE, Bolaños M, Espinosa E, González Barón M; Oncopaz cooperative group, Spain. Feliu J, et al. Among authors: lopez gomez l. Ann Oncol. 2002 Nov;13(11):1756-62. doi: 10.1093/annonc/mdf286. Ann Oncol. 2002. PMID: 12419748 Free article. Clinical Trial.
Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study.
Feliu J, Salud A, Escudero P, López-Gómez L, Pericay C, Castañón C, de Tejada MR, Rodríguez-García JM, Martínez MP, Martín MS, Sánchez JJ, Barón MG; Oncopaz Cooperative Group and Associated Hospitals. Feliu J, et al. Among authors: lopez gomez l. Br J Cancer. 2004 Apr 19;90(8):1502-7. doi: 10.1038/sj.bjc.6601713. Br J Cancer. 2004. PMID: 15083176 Free PMC article. Clinical Trial.
Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
Feliu J, Castañón C, Salud A, Mel JR, Escudero P, Pelegrín A, López-Gómez L, Ruiz M, González E, Juárez F, Lizón J, Castro J, González-Barón M; Oncopaz Cooperative Group, Spain. Feliu J, et al. Among authors: lopez gomez l. Br J Cancer. 2005 Nov 28;93(11):1230-5. doi: 10.1038/sj.bjc.6602860. Br J Cancer. 2005. PMID: 16265344 Free PMC article. Clinical Trial.
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer.
Feliu J, Salud A, Escudero P, Lopez-Gómez L, Bolaños M, Galán A, Vicent JM, Yubero A, Losa F, De Castro J, de Mon MA, Casado E, González-Barón M. Feliu J, et al. Among authors: lopez gomez l. Br J Cancer. 2006 Apr 10;94(7):969-75. doi: 10.1038/sj.bjc.6603047. Br J Cancer. 2006. PMID: 16552438 Free PMC article. Clinical Trial.
Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.
Feliu J, Borrega P, León A, López-Gómez L, López M, Castro J, Belda-Iniesta C, Barriuso J, Martínez V, González-Barón M. Feliu J, et al. Among authors: lopez gomez l, lopez m. Cancer Chemother Pharmacol. 2011 Jan;67(1):215-21. doi: 10.1007/s00280-010-1472-0. Epub 2010 Oct 7. Cancer Chemother Pharmacol. 2011. PMID: 20927525 Clinical Trial.
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Irigoyen A, Gallego J, Guillén Ponce C, Vera R, Iranzo V, Ales I, Arévalo S, Pisa A, Martín M, Salud A, Falcó E, Sáenz A, Manzano Mozo JL, Pulido G, Martínez Galán J, Pazo-Cid R, Rivera F, García García T, Serra O, Fernández Parra EM, Hurtado A, Gómez Reina MJ, López Gomez LJ, Martínez Ortega E, Benavides M, Aranda E; Spanish Cooperative Group of Treatment of Digestive Tumors (TTD). Irigoyen A, et al. Eur J Cancer. 2017 Apr;75:73-82. doi: 10.1016/j.ejca.2016.12.032. Epub 2017 Mar 7. Eur J Cancer. 2017. PMID: 28222309 Clinical Trial.
Mediastinal extravasation of doxorubicin.
Quintanar Verdúguez T, Blanco Jarava A, Martínez-Barbeito MB, Pangua Méndez C, López Gómez L, Andrade Santiago J, Chacón López-Muñiz I. Quintanar Verdúguez T, et al. Among authors: lopez gomez l. Clin Transl Oncol. 2008 Feb;10(2):128-30. doi: 10.1007/s12094-008-0167-z. Clin Transl Oncol. 2008. PMID: 18258513
75 results